Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy.
about
Developmental changes in AT1 and AT2 receptor-protein expression in ratsDanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4.Telmisartan versus valsartan in patients with hypertension: effects on cardiovascular, metabolic, and inflammatory parametersDrug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart diseaseOrganic nitrates favor regression of left ventricular hypertrophy in hypertensive patients on chronic peritoneal dialysis.Candesartan cilexetil prevents diet-induced insulin resistance via peroxisome proliferator-activated receptor-γ activation in an obese rat model.Relationship between patients' knowledge and medication adherence among patients with hypertension.Telmisartan 80 mg/hydrochlorothiazide 25 mg single-pill combination in the treatment of hypertension.
P2860
Q34557839-840E2A12-5856-4045-A238-D6E90D963E1BQ35098869-85BBD664-8814-4564-B73F-34439922661DQ35566703-E417EC20-792A-4859-BC9C-38A5204EB2C9Q35846066-44D70F67-92E2-41BC-827F-BF0896998C22Q36590001-9BB65CAA-69EE-43D6-95C1-57FA8C1B2C31Q37001374-5C5A745C-7833-46C4-9149-00B8BBCE870FQ37496556-449CE73B-B2EA-4E75-8771-875368B94214Q38050865-ED8A8479-333C-497B-9378-2D1A34C48BCD
P2860
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Choosing among renin-angiotens ...... macology to clinical efficacy.
@en
Choosing among renin-angiotens ...... macology to clinical efficacy.
@nl
type
label
Choosing among renin-angiotens ...... macology to clinical efficacy.
@en
Choosing among renin-angiotens ...... macology to clinical efficacy.
@nl
prefLabel
Choosing among renin-angiotens ...... macology to clinical efficacy.
@en
Choosing among renin-angiotens ...... macology to clinical efficacy.
@nl
P1476
Choosing among renin-angiotens ...... macology to clinical efficacy.
@en
P2093
J M Neutel
P304
P356
10.1185/03007990903444434
P407
P577
2010-01-01T00:00:00Z